NIH awards $2.1 million to UCLA to end the HIV epidemic

The National Institutes of Health (NIH) has granted $2.1 million to UCLA’s Center for HIV Identification, Prevention, and Treatment Services (CHIPTS) and the UCLA-CDU Center for AIDS Research (CFAR) to support four research projects and an implementation science consultation hub.

Zimmer Biomet’s Ivan Tornos sets priorities for first year as CEO

Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. By the numbers Q3 sales: $1.75 billion

November 7, 2023

Complete Success Rate Not as High as Expected With Gel Stent Implant for Glaucoma

While the Xen 45 gel stent implant showed beneficial long-term outcomes for the treatment of open-angle glaucoma, a substantial proportion of patients needed follow-up operations

May 31, 2024

CSPC, Alphamab Oncology make an ADC deal; Visen’s IPO in Hong Kong

Plus, news about Sequentia Biotech: CSPC, Alphamab Oncology ink ADC deal: CSPC Pharmaceutical’s JMT-Bio Technology said it will pay RMB 400 … Sign up to

October 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.